Fortrea
Jill McConnell is an accomplished financial executive currently serving as Chief Financial Officer at Fortrea since May 2023, where the organization specializes in clinical trials and post-approval patient access. Previously, Jill held the role of Chief Financial Officer at Labcorp Drug Development from September 2018 to May 2023 and was the Senior Vice President and Chief Financial Officer for ViiV Healthcare, a joint venture involving GSK, Pfizer, and Shionogi, from 2002 to August 2018. Jill's extensive career at GSK also includes various senior finance positions across different sectors, alongside an early career as a Senior Associate at Reilly, Creppage & Co, CPAs, and experience as a Senior Accountant at PwC. Jill holds an MBA in Health & Medical Services from Saint Joseph's University and dual Bachelor of Arts degrees in Management and French from Gettysburg College.
This person is not in any teams
Fortrea
11 followers
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.